查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1838590

非酒精性脂肪性肝炎市場分析及預測（至2034年）：類型、產品、服務、技術、應用、最終用戶、階段、模式和解決方案

Non alcoholic Steatohepatitis Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Stage, Mode, Solutions
出版日期: | 出版商: Global Insight Services | 英文 354 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

非酒精性脂肪性肝炎市場預計將從 2024 年的 119 億美元增加到 2034 年的 1,029 億美元，複合年成長率約為 24.1%。非酒精性脂肪性肝炎 (NASH) 市場涵蓋非酒精性脂肪堆積引起的肝臟發炎和損傷的治療方案的開發和行銷。該市場的發展受到肥胖率上升、久坐不動的生活方式以及人們對肝臟健康的認知不斷提高的推動。該市場涵蓋藥物、診斷和生活方式干涉，重點是創新治療方法和早期檢測方法。由於 NASH 可能發展為肝硬化和肝癌，對有效治療方法的需求日益成長，從而推動了這一快速成長領域的研究和投資。

非酒精性脂肪性肝炎 (NASH) 市場預計將強勁擴張，這得益於人們日益成長的認知度和盛行率。在治療領域，由於藥物研發的進步，治療領域預計將引領潮流。尤其是纖維化藥物，預計將成為該領域表現最佳的藥物，因為它們能夠有效應對疾病進展的關鍵階段。緊隨其後的是診斷領域，該領域發展勢頭強勁，反映了人們對早期精準疾病檢測的需求。影像技術和生物標記識別的創新正在提升診斷能力，使非侵入性治療方案更具吸引力。隨著整體 NASH 管理方法的興起，專注於飲食和運動的生活方式管理細分領域也正在經歷成長。製藥公司之間的策略聯盟和夥伴關係正在加速研發，進一步推動市場動態。隨著對有效 NASH 解決方案的需求不斷成長，相關人員正在增加對新型治療和診斷創新的投資。

市場區隔
類型 生物標記、治療藥物、診斷藥物
產品 藥品、生技藥品、營養補充品和醫療設備
服務 臨床試驗、諮詢服務、病患支援服務和監管服務
科技 基因體學、蛋白質體學、生物資訊學、成像技術
目的 切片檢查、影像檢查和血液檢查
最終用戶 醫院、診所、科研院所、製藥公司
階段 臨床前、I期、II期、III期
模式 侵入性、非侵入性
解決方案 治療方案、診斷方案

市場概述

非酒精性脂肪性肝炎 (NASH) 市場的特點是市場環境充滿活力，各大製藥公司都佔有相當大的市場佔有率。在創新治療方案需求旺盛的推動下，定價策略依然競爭激烈。最近推出的產品引入了突破性的治療方法，擴大了醫療保健提供者可用的治療途徑。這導致定價環境日益激烈，因為各公司透過差異化產品和策略聯盟來爭奪市場主導地位。市場研發投資激增，推動了候選藥物的推出。競爭性基準基準化分析顯示，NASH 市場競爭激烈，主要企業專注於策略併購以鞏固其市場地位。法規具有重大影響，嚴格的指導方針決定了 NASH 療法的核准和商業化。北美和歐洲的監管環境尤其具有影響力，為臨床療效和安全性設定了高標準。這些嚴格的法規，加上病人意識的提高，正在推動市場變革。新興生技公司推出創新治療方法，進而重塑市場動態，進一步加劇了競爭格局。

主要趨勢和促進因素：

由於肥胖和第 2 型糖尿病的盛行率不斷上升，非酒精性脂肪性肝炎 (NASH) 市場正在經歷顯著成長。這些疾病是 NASH 的主要風險因素，並推動了對有效治療的需求。一個關鍵趨勢是開發針對疾病進展中涉及的特定途徑的新型療法。製藥公司正在投資研究，以發現可以阻止或逆轉肝損傷的創新藥物。提高對肝臟健康和早期診斷的認知也在推動市場成長。醫療保健提供者正在強調篩檢和早期療育的重要性，從而提高患者的參與度。此外，診斷技術的進步使得 NASH 檢測方法更加準確和非侵入性。監管支持和對有前景的治療方法的加快核准流程正在進一步加速市場擴張。全球對個人化醫療的關注為客製化治療方法創造了機會，以改善患者的預後。隨著我們對 NASH 病理生理學的理解不斷加深，市場已準備好迎接創新進步和有利可圖的商機。

限制與挑戰：

非酒精性脂肪性肝炎 (NASH) 市場面臨幾個重大的限制和挑戰。一個關鍵的挑戰是準確診斷 NASH 的複雜性，這通常需要侵入性肝臟切片檢查，這對患者來說既昂貴又有風險。這種診斷的複雜性限制了早期發現和早期療育，阻礙了市場成長。另一個限制因素是缺乏專門針對 NASH 的核准治療方法，迫使人們依賴仿單標示外治療。缺乏標靶治療限制了治療選擇和市場擴張。此外，持續研發的高成本造成了經濟負擔，阻礙了中小企業進入市場。另一個挑戰是患者之間病情進展的差異，這使得臨床試驗設計和結果變得複雜。最後，醫療專業人員和患者普遍缺乏對 NASH 的認知和了解，這阻礙了早期診斷和治療，最終抑制了市場成長。

關鍵人物

Intercept Pharmaceuticals、Genfit、Madrigal Pharmaceuticals、Galmed Pharmaceuticals、Viking Therapeutics、Akero Therapeutics、89bio、Terns Pharmaceuticals、Inventiva、Cirius Therapeutics、Enyo Pharma、Conatus Pharmaceuticals、吉利德科學、艾爾建諾華科學、艾爾建諾華

目錄

第 1 章非酒精性脂肪性肝炎市場概述

  • 調查目的
  • 非酒精性脂肪性肝炎市場定義與研究範圍
  • 報告限制
  • 調查年份和貨幣
  • 調查方法

第2章執行摘要

第3章：重要考察

第4章非酒精性脂肪性肝炎市場展望

  • 非酒精性脂肪性肝炎市場細分
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 價值鏈分析
  • 4P模型
  • 安索夫矩陣

第5章非酒精性脂肪性肝炎市場策略

  • 母市場分析
  • 供需分析
  • 消費者購買興趣
  • 案例研究分析
  • 定價分析
  • 監管狀況
  • 供應鏈分析
  • 競爭產品分析
  • 近期動態

第6章非酒精性脂肪性肝炎市場規模

  • 非酒精性脂肪性肝炎市場規模（按價值）
  • 非酒精性脂肪性肝炎市場規模

第7章 非酒精性脂肪性肝炎市場規模（依類型）

  • 市場概況
  • 生物標記
  • 治療藥物
  • 診斷劑
  • 其他

第8章 非酒精性脂肪性肝炎市場（依產品）

  • 市場概況
  • 製藥
  • 生技藥品
  • 營養補充品
  • 醫療設備
  • 其他

第9章 非酒精性脂肪性肝炎市場（依服務）

  • 市場概況
  • 臨床試驗
  • 諮詢服務
  • 病人支援服務
  • 醫藥服務
  • 其他

第10章 非酒精性脂肪性肝炎市場（依技術）

  • 市場概況
  • 基因組學
  • 蛋白質體學
  • 生物資訊學
  • 成像技術
  • 其他

第 11 章非酒精性脂肪性肝炎市場（依應用）

  • 市場概況
  • 切片檢查
  • 影像檢查
  • 血液檢查
  • 其他

第 12 章非酒精性脂肪性肝炎市場（依最終用戶）

  • 市場概況
  • 醫院
  • 診所
  • 研究所
  • 製藥公司
  • 其他

第 13 章非酒精性脂肪性肝炎市場（依階段）

  • 市場概況
  • 臨床前試驗
  • 第一階段
  • 第二階段
  • 第三階段
  • 其他

第 14 章非酒精性脂肪性肝炎市場（按模式）

  • 市場概況
  • 侵入性
  • 非侵入性
  • 其他

第15章 非酒精性脂肪性肝炎市場（依解決方案）

  • 市場概況
  • 治療方案
  • 診斷解決方案
  • 其他

第16章 非酒精性脂肪性肝炎市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第17章競爭格局

  • 概述
  • 市佔率分析
  • 主要企業定位
  • 衝突領導地圖
  • 供應商基準化分析
  • 發展策略基準化分析

第18章：公司簡介

  • Intercept Pharmaceuticals
  • Genfit
  • Madrigal Pharmaceuticals
  • Galmed Pharmaceuticals
  • Viking Therapeutics
  • Akero Therapeutics
  • 89bio
  • Terns Pharmaceuticals
  • Inventiva
  • Cirius Therapeutics
  • Enyo Pharma
  • Conatus Pharmaceuticals
  • Gilead Sciences
  • Allergan
  • Novartis
簡介目錄
Product Code: GIS34087

Non alcoholic Steatohepatitis Market is anticipated to expand from $11.9 billion in 2024 to $102.9 billion by 2034, growing at a CAGR of approximately 24.1%. The Non-Alcoholic Steatohepatitis (NASH) Market encompasses the development and commercialization of therapeutic solutions targeting liver inflammation and damage due to fat accumulation, excluding alcohol-related causes. This market is driven by rising obesity rates, sedentary lifestyles, and increasing awareness of liver health. It includes pharmaceuticals, diagnostics, and lifestyle interventions, with a focus on innovative therapies and early detection methods. As NASH can progress to cirrhosis or liver cancer, the demand for effective treatments is intensifying, fostering research and investment in this burgeoning field.

The Non-Alcoholic Steatohepatitis (NASH) Market is poised for robust expansion, driven by rising awareness and increasing prevalence. Within the treatment landscape, the therapeutics segment is expected to lead, with promising advancements in drug development. Specifically, the fibrosis treatment sub-segment is anticipated to be the top-performing area, as it addresses critical disease progression stages. Following closely, the diagnostic segment is gaining momentum, reflecting the need for early and accurate disease detection. Innovations in imaging techniques and biomarker identification are enhancing diagnostic capabilities, making non-invasive options more appealing. The lifestyle management sub-segment, focusing on dietary and exercise interventions, is also witnessing growth, as holistic approaches to managing NASH gain traction. Strategic collaborations and partnerships among pharmaceutical companies are accelerating research and development efforts, further propelling market dynamics. As the demand for effective NASH solutions intensifies, stakeholders are increasingly investing in novel therapeutic and diagnostic innovations.

Market Segmentation
TypeBiomarkers, Therapeutics, Diagnostics
ProductPharmaceuticals, Biologics, Nutraceuticals, Medical Devices
ServicesClinical Trials, Consulting Services, Patient Support Services, Regulatory Services
TechnologyGenomics, Proteomics, Bioinformatics, Imaging Technologies
ApplicationLiver Biopsy, Imaging Tests, Blood Tests
End UserHospitals, Clinics, Research Institutes, Pharmaceutical Companies
StagePreclinical, Phase I, Phase II, Phase III
ModeInvasive, Non-Invasive
SolutionsTherapeutic Solutions, Diagnostic Solutions

Market Snapshot:

The Non-Alcoholic Steatohepatitis (NASH) market is characterized by a dynamic landscape, with significant market share held by key pharmaceutical giants. Pricing strategies remain competitive, influenced by the high demand for innovative therapeutic solutions. Recent product launches have introduced groundbreaking treatments, enhancing the therapeutic arsenal available to healthcare providers. This has led to a competitive pricing environment, as companies vie for market dominance through differentiated product offerings and strategic partnerships. The market is witnessing a surge in research and development investments, driving the introduction of novel drug candidates. In terms of competition benchmarking, the NASH market is intensely competitive, with major players focusing on strategic mergers and acquisitions to bolster their market positions. Regulatory influences are pivotal, with stringent guidelines shaping the approval and commercialization of NASH therapies. The regulatory landscape in North America and Europe is particularly influential, setting high standards for clinical efficacy and safety. This regulatory rigor, coupled with increasing patient awareness, is driving the market's evolution. The competitive landscape is further intensified by emerging biotechnology firms, which are introducing innovative therapeutic approaches, thereby reshaping market dynamics.

Geographical Overview:

The Non-Alcoholic Steatohepatitis (NASH) market is witnessing varied growth across regions, each presenting unique opportunities. North America leads, driven by high obesity rates and rising awareness of liver diseases. The presence of key pharmaceutical companies investing in research and development further propels market growth. Europe follows, with increasing healthcare expenditure and a growing prevalence of lifestyle-related diseases enhancing market prospects. The Asia Pacific region is emerging rapidly, fueled by rising healthcare awareness and improving healthcare infrastructure. Countries like China and India are witnessing significant growth due to an increasing patient pool and government initiatives supporting liver disease research. Latin America shows potential, with Brazil and Mexico at the forefront, driven by lifestyle changes and improved healthcare access. The Middle East & Africa are nascent markets, with countries like Saudi Arabia recognizing the importance of addressing liver diseases, thus offering new growth pockets for NASH therapeutics.

Key Trends and Drivers:

The Non-Alcoholic Steatohepatitis (NASH) market is experiencing notable growth due to increasing prevalence of obesity and type 2 diabetes. These conditions are major risk factors for NASH, driving demand for effective treatments. A significant trend is the development of novel therapeutics targeting specific pathways involved in disease progression. Pharmaceutical companies are investing in research to discover innovative drugs that can halt or reverse liver damage. Rising awareness about liver health and early diagnosis is also propelling market growth. Healthcare providers are emphasizing the importance of screening and early intervention, leading to increased patient engagement. Additionally, advancements in diagnostic technologies are enabling more accurate and non-invasive methods for NASH detection. Regulatory support and expedited approval processes for promising therapies are further accelerating market expansion. The global focus on personalized medicine is creating opportunities for tailored treatment approaches, enhancing patient outcomes. As the understanding of NASH pathophysiology deepens, the market is poised for transformative advancements and lucrative opportunities.

Restraints and Challenges:

The Non-Alcoholic Steatohepatitis (NASH) market is confronted with several significant restraints and challenges. A primary challenge is the complexity of accurately diagnosing NASH, as it often requires invasive liver biopsies, which are both costly and risky for patients. This diagnostic complexity limits early detection and intervention, impeding market growth. Another constraint is the lack of approved therapies specifically targeting NASH, which results in a reliance on off-label treatments. This absence of targeted therapies limits treatment options and market expansion. Furthermore, the high cost of ongoing research and development poses a financial burden, deterring smaller companies from entering the market. The market also faces challenges due to the variability in disease progression among patients, complicating clinical trial designs and outcomes. Lastly, there is a general lack of awareness and understanding of NASH among both healthcare providers and patients, which hampers early diagnosis and treatment efforts, ultimately restraining market growth.

Key Players:

Intercept Pharmaceuticals, Genfit, Madrigal Pharmaceuticals, Galmed Pharmaceuticals, Viking Therapeutics, Akero Therapeutics, 89bio, Terns Pharmaceuticals, Inventiva, Cirius Therapeutics, Enyo Pharma, Conatus Pharmaceuticals, Gilead Sciences, Allergan, Novartis

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Non alcoholic Steatohepatitis Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Non alcoholic Steatohepatitis Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Stage
  • 2.10 Key Highlights of the Market, by Mode
  • 2.11 Key Highlights of the Market, by Solutions
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Stage
  • 3.9 Market Attractiveness Analysis, by Mode
  • 3.10 Market Attractiveness Analysis, by Solutions
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Non alcoholic Steatohepatitis Market Outlook

  • 4.1 Non alcoholic Steatohepatitis Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Non alcoholic Steatohepatitis Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Non alcoholic Steatohepatitis Market Size

  • 6.1 Non alcoholic Steatohepatitis Market Size, by Value
  • 6.2 Non alcoholic Steatohepatitis Market Size, by Volume

7: Non alcoholic Steatohepatitis Market, by Type

  • 7.1 Market Overview
  • 7.2 Biomarkers
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Therapeutics
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Diagnostics
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Others
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region

8: Non alcoholic Steatohepatitis Market, by Product

  • 8.1 Market Overview
  • 8.2 Pharmaceuticals
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Biologics
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Nutraceuticals
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Medical Devices
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Non alcoholic Steatohepatitis Market, by Services

  • 9.1 Market Overview
  • 9.2 Clinical Trials
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Consulting Services
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Patient Support Services
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Regulatory Services
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Non alcoholic Steatohepatitis Market, by Technology

  • 10.1 Market Overview
  • 10.2 Genomics
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Proteomics
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Bioinformatics
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Imaging Technologies
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: Non alcoholic Steatohepatitis Market, by Application

  • 11.1 Market Overview
  • 11.2 Liver Biopsy
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Imaging Tests
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Blood Tests
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: Non alcoholic Steatohepatitis Market, by End User

  • 12.1 Market Overview
  • 12.2 Hospitals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Clinics
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Pharmaceutical Companies
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: Non alcoholic Steatohepatitis Market, by Stage

  • 13.1 Market Overview
  • 13.2 Preclinical
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Phase I
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Phase II
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Phase III
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Others
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region

14: Non alcoholic Steatohepatitis Market, by Mode

  • 14.1 Market Overview
  • 14.2 Invasive
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Non-Invasive
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: Non alcoholic Steatohepatitis Market, by Solutions

  • 15.1 Market Overview
  • 15.2 Therapeutic Solutions
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Diagnostic Solutions
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Non alcoholic Steatohepatitis Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Application
    • 16.2.7 North America Market Size and Forecast, by End User
    • 16.2.8 North America Market Size and Forecast, by Stage
    • 16.2.9 North America Market Size and Forecast, by Mode
    • 16.2.10 North America Market Size and Forecast, by Solutions
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Application
      • 16.2.9.6 United States Market Size and Forecast, by End User
      • 16.2.9.7 United States Market Size and Forecast, by Stage
      • 16.2.9.8 United States Market Size and Forecast, by Mode
      • 16.2.9.9 United States Market Size and Forecast, by Solutions
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Application
      • 16.2.10.6 Canada Market Size and Forecast, by End User
      • 16.2.10.7 Canada Market Size and Forecast, by Stage
      • 16.2.10.8 Canada Market Size and Forecast, by Mode
      • 16.2.10.9 Canada Market Size and Forecast, by Solutions
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Application
    • 16.3.7 Europe Market Size and Forecast, by End User
    • 16.3.8 Europe Market Size and Forecast, by Stage
    • 16.3.9 Europe Market Size and Forecast, by Mode
    • 16.3.10 Europe Market Size and Forecast, by Solutions
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Mode
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Solutions
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Application
      • 16.3.10.6 Germany Market Size and Forecast, by End User
      • 16.3.10.7 Germany Market Size and Forecast, by Stage
      • 16.3.10.8 Germany Market Size and Forecast, by Mode
      • 16.3.10.9 Germany Market Size and Forecast, by Solutions
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Application
      • 16.3.11.6 France Market Size and Forecast, by End User
      • 16.3.11.7 France Market Size and Forecast, by Stage
      • 16.3.11.8 France Market Size and Forecast, by Mode
      • 16.3.11.9 France Market Size and Forecast, by Solutions
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Application
      • 16.3.12.6 Spain Market Size and Forecast, by End User
      • 16.3.12.7 Spain Market Size and Forecast, by Stage
      • 16.3.12.8 Spain Market Size and Forecast, by Mode
      • 16.3.12.9 Spain Market Size and Forecast, by Solutions
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Application
      • 16.3.13.6 Italy Market Size and Forecast, by End User
      • 16.3.13.7 Italy Market Size and Forecast, by Stage
      • 16.3.13.8 Italy Market Size and Forecast, by Mode
      • 16.3.13.9 Italy Market Size and Forecast, by Solutions
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Application
      • 16.3.14.6 Netherlands Market Size and Forecast, by End User
      • 16.3.14.7 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.8 Netherlands Market Size and Forecast, by Mode
      • 16.3.14.9 Netherlands Market Size and Forecast, by Solutions
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Application
      • 16.3.15.6 Sweden Market Size and Forecast, by End User
      • 16.3.15.7 Sweden Market Size and Forecast, by Stage
      • 16.3.15.8 Sweden Market Size and Forecast, by Mode
      • 16.3.15.9 Sweden Market Size and Forecast, by Solutions
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Application
      • 16.3.16.6 Switzerland Market Size and Forecast, by End User
      • 16.3.16.7 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.8 Switzerland Market Size and Forecast, by Mode
      • 16.3.16.9 Switzerland Market Size and Forecast, by Solutions
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Application
      • 16.3.17.6 Denmark Market Size and Forecast, by End User
      • 16.3.17.7 Denmark Market Size and Forecast, by Stage
      • 16.3.17.8 Denmark Market Size and Forecast, by Mode
      • 16.3.17.9 Denmark Market Size and Forecast, by Solutions
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Application
      • 16.3.18.6 Finland Market Size and Forecast, by End User
      • 16.3.18.7 Finland Market Size and Forecast, by Stage
      • 16.3.18.8 Finland Market Size and Forecast, by Mode
      • 16.3.18.9 Finland Market Size and Forecast, by Solutions
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Application
      • 16.3.19.6 Russia Market Size and Forecast, by End User
      • 16.3.19.7 Russia Market Size and Forecast, by Stage
      • 16.3.19.8 Russia Market Size and Forecast, by Mode
      • 16.3.19.9 Russia Market Size and Forecast, by Solutions
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Mode
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Solutions
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Mode
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Solutions
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Application
      • 16.4.9.6 China Market Size and Forecast, by End User
      • 16.4.9.7 China Market Size and Forecast, by Stage
      • 16.4.9.8 China Market Size and Forecast, by Mode
      • 16.4.9.9 China Market Size and Forecast, by Solutions
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Application
      • 16.4.10.6 India Market Size and Forecast, by End User
      • 16.4.10.7 India Market Size and Forecast, by Stage
      • 16.4.10.8 India Market Size and Forecast, by Mode
      • 16.4.10.9 India Market Size and Forecast, by Solutions
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Application
      • 16.4.11.6 Japan Market Size and Forecast, by End User
      • 16.4.11.7 Japan Market Size and Forecast, by Stage
      • 16.4.11.8 Japan Market Size and Forecast, by Mode
      • 16.4.11.9 Japan Market Size and Forecast, by Solutions
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Application
      • 16.4.12.6 South Korea Market Size and Forecast, by End User
      • 16.4.12.7 South Korea Market Size and Forecast, by Stage
      • 16.4.12.8 South Korea Market Size and Forecast, by Mode
      • 16.4.12.9 South Korea Market Size and Forecast, by Solutions
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Application
      • 16.4.13.6 Australia Market Size and Forecast, by End User
      • 16.4.13.7 Australia Market Size and Forecast, by Stage
      • 16.4.13.8 Australia Market Size and Forecast, by Mode
      • 16.4.13.9 Australia Market Size and Forecast, by Solutions
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Application
      • 16.4.14.6 Singapore Market Size and Forecast, by End User
      • 16.4.14.7 Singapore Market Size and Forecast, by Stage
      • 16.4.14.8 Singapore Market Size and Forecast, by Mode
      • 16.4.14.9 Singapore Market Size and Forecast, by Solutions
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Application
      • 16.4.15.6 Indonesia Market Size and Forecast, by End User
      • 16.4.15.7 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.8 Indonesia Market Size and Forecast, by Mode
      • 16.4.15.9 Indonesia Market Size and Forecast, by Solutions
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Application
      • 16.4.16.6 Taiwan Market Size and Forecast, by End User
      • 16.4.16.7 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.8 Taiwan Market Size and Forecast, by Mode
      • 16.4.16.9 Taiwan Market Size and Forecast, by Solutions
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Application
      • 16.4.17.6 Malaysia Market Size and Forecast, by End User
      • 16.4.17.7 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.8 Malaysia Market Size and Forecast, by Mode
      • 16.4.17.9 Malaysia Market Size and Forecast, by Solutions
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Solutions
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Application
    • 16.5.7 Latin America Market Size and Forecast, by End User
    • 16.5.8 Latin America Market Size and Forecast, by Stage
    • 16.5.9 Latin America Market Size and Forecast, by Mode
    • 16.5.10 Latin America Market Size and Forecast, by Solutions
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Application
      • 16.5.9.6 Brazil Market Size and Forecast, by End User
      • 16.5.9.7 Brazil Market Size and Forecast, by Stage
      • 16.5.9.8 Brazil Market Size and Forecast, by Mode
      • 16.5.9.9 Brazil Market Size and Forecast, by Solutions
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Application
      • 16.5.10.6 Mexico Market Size and Forecast, by End User
      • 16.5.10.7 Mexico Market Size and Forecast, by Stage
      • 16.5.10.8 Mexico Market Size and Forecast, by Mode
      • 16.5.10.9 Mexico Market Size and Forecast, by Solutions
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Application
      • 16.5.11.6 Argentina Market Size and Forecast, by End User
      • 16.5.11.7 Argentina Market Size and Forecast, by Stage
      • 16.5.11.8 Argentina Market Size and Forecast, by Mode
      • 16.5.11.9 Argentina Market Size and Forecast, by Solutions
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Mode
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Solutions
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Mode
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Solutions
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Mode
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Solutions
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Application
      • 16.6.10.6 UAE Market Size and Forecast, by End User
      • 16.6.10.7 UAE Market Size and Forecast, by Stage
      • 16.6.10.8 UAE Market Size and Forecast, by Mode
      • 16.6.10.9 UAE Market Size and Forecast, by Solutions
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Application
      • 16.6.11.6 South Africa Market Size and Forecast, by End User
      • 16.6.11.7 South Africa Market Size and Forecast, by Stage
      • 16.6.11.8 South Africa Market Size and Forecast, by Mode
      • 16.6.11.9 South Africa Market Size and Forecast, by Solutions
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Mode
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Solutions
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Intercept Pharmaceuticals
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Genfit
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Madrigal Pharmaceuticals
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Galmed Pharmaceuticals
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Viking Therapeutics
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Akero Therapeutics
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 89bio
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Terns Pharmaceuticals
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Inventiva
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Cirius Therapeutics
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Enyo Pharma
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Conatus Pharmaceuticals
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Gilead Sciences
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Allergan
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Novartis
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis